This site is intended for healthcare professionals
Glaucoma Learning Zone
Declaration of sponsorship Novartis Pharma AG

Welcome

Declaration of sponsorship Novartis Pharma AG
Read time: 155 mins
Last updated:9th Jun 2022
Published:9th Jun 2022

How much do you know about glaucoma? Enhance your knowledge of this disease of global concern.

  • Find out the risk factors, signs and symptoms of glaucoma
  • Discover strategies for screening and diagnosis
  • Watch short videos featuring glaucoma experts to learn about treatment options and patient management considerations

This expert-reviewed Learning Zone contains a wealth of educational material designed to strengthen your knowledge of glaucoma. It contains information and resources on glaucoma risk factors, the unmet needs for diagnosis, strategies for screening and diagnosis, and treatment options. You will also learn about the increasing prevalence and burden of the disease.

It is projected that by 2040, there will be 112 million cases of glaucoma globally1

Find out the signs, symptoms and risk factors for glaucoma so you can screen people who are at greatest risk. Earlier diagnosis can lead to earlier treatment and preserve vision, helping prevent irreversible blindness.

Meet the experts

Professor Anthony King

Professor Anthony King is Honorary Professor of Clinical Ophthalmology and Consultant Ophthalmic Surgeon at Nottingham University Hospital.

Disclosures: Professor Anthony King received honorarium from EPG Health to participate in this programme.

Professor Ingrida Janulevičienė

Professor Ingrida Janulevičienė is Head of the Outpatient Department at the Eye Clinic of the Lithuanian University of Health Sciences in Kaunas, Lithuania.

Disclosures: Professor Ingrida Janulevičienė received honorarium from EPG Health to participate in this programme.

References

  1. Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014;121(11):2081-2090.
Welcome: